Understanding zinc supplementation risks requires awareness of three key evidence-based facts. First, even standard 50mg daily zinc doses significantly impair copper-dependent enzyme function, reducing activity by nearly half within 10 weeks. Second, this depletion remains invisible to conventional copper monitoring, including serum ceruloplasmin testing, leaving patients and clinicians unaware of functional deficiency.
Third—and perhaps most importantly—simply adding copper supplementation cannot reliably overcome the metallothionein trapping mechanism. The zinc-induced metallothionein protein continues to sequester copper in intestinal cells regardless of oral copper intake, making this an issue of bioavailability rather than absolute intake.
These findings suggest that zinc supplementation protocols should incorporate careful dose selection and consideration of cumulative mineral balance rather than treating micronutrients as independent interventions.
Was this article helpful?
